Interleukin-17 in systemic lupus erythematosus: A comprehensive review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-17 in systemic lupus erythematosus: A comprehensive review
Authors
Keywords
-
Journal
AUTOIMMUNITY
Volume 48, Issue 6, Pages 353-361
Publisher
Informa UK Limited
Online
2015-04-20
DOI
10.3109/08916934.2015.1037441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice
- (2014) Shin Ebihara et al. AUTOIMMUNITY
- Not all monoclonals are created equal – Lessons from failed drug trials in Crohn's disease
- (2014) Arthur Kaser BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The Role of Interleukin-17A in Psoriatic Disease
- (2014) Silvano Adami et al. BIODRUGS
- The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes
- (2014) Gaelle Elain et al. GLIA
- Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
- (2014) Vibeke Strand et al. Health and Quality of Life Outcomes
- CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
- (2014) Tomohiro Koga et al. JOURNAL OF CLINICAL INVESTIGATION
- Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
- (2014) J. C. Crispin et al. JOURNAL OF IMMUNOLOGY
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial
- (2014) C. Paul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Antibodies to watch in 2014
- (2014) Janice M Reichert mAbs
- The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus
- (2014) Lucy E Ballantine et al. Pediatric Rheumatology
- Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Enhanced Rho-Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus
- (2013) Josephine Isgro et al. ARTHRITIS AND RHEUMATISM
- Treatment of spondyloarthropathy
- (2013) Minyoung Her et al. CURRENT OPINION IN RHEUMATOLOGY
- ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis
- (2013) Houpu Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-17 targeted therapies for psoriasis
- (2013) Andrea Chiricozzi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Treating multiple sclerosis with monoclonal antibodies: a 2013 update
- (2013) Annika Deiß et al. Expert Review of Neurotherapeutics
- Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells
- (2013) Yutaka Kurebayashi et al. GENES TO CELLS
- Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis
- (2013) Leon P McLean et al. Immunotherapy
- Inhibition of IL-17 as a Pharmacological Approach for IBD
- (2013) Leo R. Fitzpatrick INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Protein Phosphatase 2A Enables Expression of Interleukin 17 (IL-17) through Chromatin Remodeling
- (2013) Sokratis A. Apostolidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study
- (2013) B. Sigurgeirsson et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Pragmatic approaches to therapy for systemic lupus erythematosus
- (2013) Wen Xiong et al. Nature Reviews Rheumatology
- The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside
- (2013) Desmond Yat Hin Yap et al. NEPHROLOGY
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials
- (2013) Andrew D. Dick et al. OPHTHALMOLOGY
- Interleukin-17 Expression Positively Correlates with Disease Severity of Lupus Nephritis by Increasing Anti-Double-Stranded DNA Antibody Production in a Lupus Model Induced by Activated Lymphocyte Derived DNA
- (2013) Zhenke Wen et al. PLoS One
- Clinical associations of serum interleukin-17 in systemic lupus erythematosus
- (2013) Fabien B Vincent et al. ARTHRITIS RESEARCH & THERAPY
- Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential
- (2013) Herbert Kellner Therapeutic Advances in Musculoskeletal Disease
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Plasticity of DNA methylation in mouse T cell activation and differentiation
- (2012) Yan Li et al. BMC MOLECULAR BIOLOGY
- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal
- (2012) Ph. I. Spuls et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine
- (2012) Michael H. Shaw et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus
- (2012) A Rana et al. LUPUS
- The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis
- (2012) D-Y Chen et al. LUPUS
- cAMP response element modulator controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus
- (2012) C. M. Hedrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell receptor/CARMA1/NF- B signaling controls T-helper (Th) 17 differentiation
- (2012) L. L. Molinero et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORγ
- (2012) Yutaka Kurebayashi et al. Cell Reports
- TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
- (2012) Ashish K. Marwaha et al. Frontiers in Immunology
- High Levels of Maternal Serum IL-17 and Activin A in Pregnant Women Affected by Systemic Lupus Erythematosus
- (2011) Michela Torricelli et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus
- (2011) Bo Yu et al. ARTHRITIS AND RHEUMATISM
- Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues
- (2011) Ana Henriques et al. CLINICAL RHEUMATOLOGY
- cAMP-responsive Element Modulator α (CREMα) Suppresses IL-17F Protein Expression in T Lymphocytes from Patients with Systemic Lupus Erythematosus (SLE)
- (2011) Christian M. Hedrich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- cAMP-responsive Element Modulator (CREM)α Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus
- (2011) Thomas Rauen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Th Subset Balance in Lupus Nephritis
- (2011) Katsuhisa Miyake et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis
- (2011) Qian Xing et al. RHEUMATOLOGY INTERNATIONAL
- Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
- (2011) Sebastian Dolff et al. ARTHRITIS RESEARCH & THERAPY
- Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis
- (2010) Cheng-Chi Chao et al. AUTOIMMUNITY
- IL-17 in cutaneous lupus erythematosus
- (2010) C. Tanasescu et al. European Journal of Internal Medicine
- The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase Activation
- (2010) Muhammet F. Gulen et al. IMMUNITY
- Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
- (2010) Reiko M. Onishi et al. IMMUNOLOGY
- Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease Activity
- (2010) Xiao Qi Chen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Profiling of CD4+ T Cells with Epigenetic Immune Lineage Analysis
- (2010) P. C. J. Janson et al. JOURNAL OF IMMUNOLOGY
- The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus
- (2010) M. Y. MOK et al. JOURNAL OF RHEUMATOLOGY
- Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection
- (2010) XY Lu et al. LUPUS
- B-cell Biology and Related Therapies in Systemic Lupus Erythematosus
- (2010) Sadia Ahmed et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus
- (2010) Sebastian Dolff et al. ARTHRITIS RESEARCH & THERAPY
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
- Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis
- (2009) Y. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells
- (2009) Gang Wei et al. IMMUNITY
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Th17 cells in rheumatoid arthritis and systemic lupus erythematosus
- (2009) A. B. Pernis JOURNAL OF INTERNAL MEDICINE
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
- (2009) Agnès Doreau et al. NATURE IMMUNOLOGY
- The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus
- (2009) B. C.-H. Kwan et al. RHEUMATOLOGY
- The inflammatory Th 17 subset in immunity against self and non-self antigens
- (2008) Di Jin et al. AUTOIMMUNITY
- T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis
- (2008) Robert A. Cohen et al. CLINICAL IMMUNOLOGY
- IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
- (2008) Colin Edgerton et al. CLINICAL IMMUNOLOGY
- An overview of IL-17 function and signaling
- (2008) Sarah L. Gaffen CYTOKINE
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages
- (2008) Roza I. Nurieva et al. IMMUNITY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- Epigenetic regulation and the pathogenesis of systemic lupus erythematosus
- (2008) Yujun Pan et al. Translational Research
- Regulation of IL-17 production in human lymphocytes
- (2007) Zhi Chen et al. CYTOKINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started